Skip to content
10-Q

Quarterly Report

Bolt Biotherapeutics, Inc. BOLT

0000950170-25-069188

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 5, 2025 38.34M sh
Short Term Investments Q1 2025 · Mar 31, 2025 $30.45M
Short Term Investments Q1 2025 · Dec 31, 2024 $40.12M
Current Liabilities Q1 2025 · Mar 31, 2025 $13.56M
Current Liabilities Q1 2025 · Dec 31, 2024 $15.86M
Total Liabilities Q1 2025 · Mar 31, 2025 $39.05M
Total Liabilities Q1 2025 · Dec 31, 2024 $42.43M
Current Assets Q1 2025 · Mar 31, 2025 $42.51M
Current Assets Q1 2025 · Dec 31, 2024 $50.81M
Total Assets Q1 2025 · Mar 31, 2025 $85.86M
Total Assets Q1 2025 · Dec 31, 2024 $99.63M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $7.21M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $4.26M
Shares Diluted Q1 2025 · Mar 31, 2024 38.07M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$16.75M
Stockholders Equity Q1 2025 · Mar 31, 2024 $104.16M
Stockholders Equity Q1 2025 · Dec 31, 2023 $112.74M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.28
Eps Basic Q1 2025 · Mar 31, 2024 −$0.28
Sga Expense Q1 2025 · Mar 31, 2024 $5.84M
Rd Expense Q1 2025 · Mar 31, 2024 $16.53M
Net Income Q1 2025 · Mar 31, 2024 −$10.81M
Operating Income Q1 2025 · Mar 31, 2024 −$17.09M
Revenue Q1 2025 · Mar 31, 2024 $5.27M